Remove Design Remove Early Stage Remove Philadelphia Remove Technical Review
article thumbnail

Finalist Women and Minority Entrepreneurs Named in VCAP Program

David Teten

After a highly competitive national selection process designed to identify high growth potential start ups led by women and minorities, six companies have been selected to present to HBSAANY accredited investors. Tiger Trade ( www.tigertrade.com , New York, NY) makes international sourcing fast, easy, and cost-effective. domestic market.

article thumbnail

Finalist Women and Minority Entrepreneurs Named in VCAP Program

David Teten

After a highly competitive national selection process designed to identify high growth potential start ups led by women and minorities, six companies have been selected to present to HBSAANY accredited investors. Tiger Trade ( www.tigertrade.com , New York, NY) makes international sourcing fast, easy, and cost-effective. domestic market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What is Sweat Equity Worth?

www.entrepreneur.com

Technology Technology Home Online Business Tools Security Phones & Mobile Gadgets Tech Tips Technology The Future of Facebook -- Streaming Live Now. Product Reviews Mindjet Connect Helps Small Businesses Visualize and Manage Projects. Sweat equity is just one component of early-stage valuation.

article thumbnail

How to Fund a Startup

www.paulgraham.com

I wassurprised recently when I realized that all the worst problems wefaced in our startup were due not to competitors, but investors.Dealing with competitors was easy by comparison. Angels whove made money in technology are preferable,for two reasons: they understand your situation, and theyre asource of contacts and advice.

article thumbnail

Reinventing Life Science Startups–Therapeutics and Diagnostics

Steve Blank

has gone offshore primarily due to the toughened regulatory environment. It has gotten so bad that pension funds and other institutional investors in venture capital funds have told these funds to stay away from Life Science – or at the least, early stage Life Science. Pharma companies are staggering under the costs.